Upifitamab (Anti-SLC34A2)
A2351
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameUpifitamab (Anti-SLC34A2)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionUpifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203